CHINARES PHARMA(03320): Cheng Jie appointed as Executive Director and President.
China Resources Pharmaceutical Group (03320) announced that as of August 26, 2025, Mr. Taoran has resigned as an executive director and executive...
CHINARES PHARMA (03320) announced that as of August 26, 2025, Mr. Taoran resigned as Executive Director and member of the Executive Committee; Mr. Cheng Jie was appointed as Executive Director, President, member of the Executive Committee, and Corporate Governance Committee; and Ms. Deng Rong resigned as a member of the Corporate Governance Committee.
Related Articles
Tianjin Lisheng Pharmaceutical (002393.SZ): Potassium chloride sustained-release tablets approved through listing permit application
HK Stock Market Move | TCL Electronics (01070) rose nearly 5% at the close. The company's innovative business performance in the first half of the year was impressive, and the company is actively promoting the implementation of smart and AI applications.
Zhongjin: "Anti-internal incision" market encounters obstacles, black industry seeks solutions from top to bottom
Tianjin Lisheng Pharmaceutical (002393.SZ): Potassium chloride sustained-release tablets approved through listing permit application
HK Stock Market Move | TCL Electronics (01070) rose nearly 5% at the close. The company's innovative business performance in the first half of the year was impressive, and the company is actively promoting the implementation of smart and AI applications.
Zhongjin: "Anti-internal incision" market encounters obstacles, black industry seeks solutions from top to bottom
RECOMMEND
Alibaba and Meituan Spend Billions, Yet the True Winners of the Food Delivery Battle Have Emerged
25/08/2025
Hong Kong Overtakes the U.S. as Mainland Companies’ Premier Offshore Listing Venue
25/08/2025
General Administration of Customs Reports Record Trade Oversight Since the 14th Five-Year Plan
25/08/2025
